EDOR researcher Associate Professor Lynne Chepulis, University of Waikato, has co-authored an article for The Conversation on why a new Barbie doll with type 1 diabetes is an important step towards a wider understanding and acceptance of those living with this condition.
Type 1 diabetes is one of the most common chronic diseases diagnosed in childhood and affects around 2,600 children and adolescents in Aotearoa New Zealand, as well as more than 20,000 adults.
Unlike type 2 diabetes, type 1 diabetes is an auto-immune disease. Cells in the pancreas which help control blood sugar levels (by secreting insulin) are destroyed by the immune system and therefore people who develop this disease have a considerable life-long burden of managing their blood sugar (glucose) levels.
People with type 1 diabetes need to take insulin every day. This is delivered through multiple injections or by wearing an insulin pump which has a flexible plastic tube (cannula) inserted under the skin.
They also need to check their blood glucose regularly during the day, using finger pricks or via a continuous glucose monitor worn on the skin (usually the upper arm).
The new Barbie doll with type 1 diabetes has a visible insulin pump and a continuous glucose monitor. Associate Professor Chepulis says that making the devices that are essential for managing this condition more accepted will help normalise the experience of those living with type 1 diabetes.
Reducing any stigma that children may feel when using their insulin pumps or checking their blood sugar in public will also lead to better management of the condition and improved health outcomes in the long-term.
Access The Conversation article
New Barbie with type 1 diabetes could help kids with the condition feel seen – and help others learn. The Conversation, 18 July, 2025